NDC 0703-4680
mitoXANTRONE
Mitoxantrone
mitoXANTRONE is a Intravenous Injection, Solution, Concentrate in the Human Prescription Drug category. It is labeled and distributed by Teva Parenteral Medicines, Inc.. The primary component is Mitoxantrone Hydrochloride.
Product ID | 0703-4680_031f9934-217e-40c4-b623-92a44b5831ac |
NDC | 0703-4680 |
Product Type | Human Prescription Drug |
Proprietary Name | mitoXANTRONE |
Generic Name | Mitoxantrone |
Dosage Form | Injection, Solution, Concentrate |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2006-04-11 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA077356 |
Labeler Name | Teva Parenteral Medicines, Inc. |
Substance Name | MITOXANTRONE HYDROCHLORIDE |
Active Ingredient Strength | 2 mg/mL |
Pharm Classes | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |